190 related articles for article (PubMed ID: 36945114)
1. RHAMM marks proliferative subpopulation of human colorectal cancer stem cells.
Nakano M; Taguchi R; Kikushige Y; Isobe T; Miyawaki K; Mizuno S; Tsuruta N; Hanamura F; Yamaguchi K; Yamauchi T; Ariyama H; Kusaba H; Nakamura M; Maeda T; Kuo CJ; Baba E; Akashi K
Cancer Sci; 2023 Jul; 114(7):2895-2906. PubMed ID: 36945114
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of CD44 and CD133 as cancer stem cell markers for colorectal cancer.
Wang C; Xie J; Guo J; Manning HC; Gore JC; Guo N
Oncol Rep; 2012 Oct; 28(4):1301-8. PubMed ID: 22895640
[TBL] [Abstract][Full Text] [Related]
3. Lgr5+CD44+EpCAM+ Strictly Defines Cancer Stem Cells in Human Colorectal Cancer.
Leng Z; Xia Q; Chen J; Li Y; Xu J; Zhao E; Zheng H; Ai W; Dong J
Cell Physiol Biochem; 2018; 46(2):860-872. PubMed ID: 29627827
[TBL] [Abstract][Full Text] [Related]
4. CD133+, CD166+CD44+, and CD24+CD44+ phenotypes fail to reliably identify cell populations with cancer stem cell functional features in established human colorectal cancer cell lines.
Muraro MG; Mele V; Däster S; Han J; Heberer M; Cesare Spagnoli G; Iezzi G
Stem Cells Transl Med; 2012 Aug; 1(8):592-603. PubMed ID: 23197865
[TBL] [Abstract][Full Text] [Related]
5. Spheroid-Formation (Colonosphere) Assay for in Vitro Assessment and Expansion of Stem Cells in Colon Cancer.
Shaheen S; Ahmed M; Lorenzi F; Nateri AS
Stem Cell Rev Rep; 2016 Aug; 12(4):492-9. PubMed ID: 27207017
[TBL] [Abstract][Full Text] [Related]
6. Radiation-induced glucocorticoid receptor promotes CD44+ prostate cancer stem cell growth through activation of SGK1-Wnt/β-catenin signaling.
Chen F; Chen X; Ren Y; Weng G; Keng PC; Chen Y; Lee SO
J Mol Med (Berl); 2019 Aug; 97(8):1169-1182. PubMed ID: 31187175
[TBL] [Abstract][Full Text] [Related]
7. Maintenance of stem cell self-renewal in head and neck cancers requires actions of GSK3β influenced by CD44 and RHAMM.
Shigeishi H; Biddle A; Gammon L; Emich H; Rodini CO; Gemenetzidis E; Fazil B; Sugiyama M; Kamata N; Mackenzie IC
Stem Cells; 2013 Oct; 31(10):2073-83. PubMed ID: 23649588
[TBL] [Abstract][Full Text] [Related]
8. Triptolide suppresses the in vitro and in vivo growth of lung cancer cells by targeting hyaluronan-CD44/RHAMM signaling.
Song JM; Molla K; Anandharaj A; Cornax I; O Sullivan MG; Kirtane AR; Panyam J; Kassie F
Oncotarget; 2017 Apr; 8(16):26927-26940. PubMed ID: 28460475
[TBL] [Abstract][Full Text] [Related]
9. Identification of gastric cancer stem cells using the cell surface marker CD44.
Takaishi S; Okumura T; Tu S; Wang SS; Shibata W; Vigneshwaran R; Gordon SA; Shimada Y; Wang TC
Stem Cells; 2009 May; 27(5):1006-20. PubMed ID: 19415765
[TBL] [Abstract][Full Text] [Related]
10. Cancer stem cells from colorectal cancer-derived cell lines.
Yeung TM; Gandhi SC; Wilding JL; Muschel R; Bodmer WF
Proc Natl Acad Sci U S A; 2010 Feb; 107(8):3722-7. PubMed ID: 20133591
[TBL] [Abstract][Full Text] [Related]
11. Cancer stem cells enrichment with surface markers CD271 and CD44 in human head and neck squamous cell carcinomas.
Elkashty OA; Abu Elghanam G; Su X; Liu Y; Chauvin PJ; Tran SD
Carcinogenesis; 2020 Jun; 41(4):458-466. PubMed ID: 31742606
[TBL] [Abstract][Full Text] [Related]
12. c-KIT regulates stability of cancer stemness in CD44-positive colorectal cancer cells.
Tomizawa F; Jang MK; Mashima T; Seimiya H
Biochem Biophys Res Commun; 2020 Jul; 527(4):1014-1020. PubMed ID: 32439168
[TBL] [Abstract][Full Text] [Related]
13. Radiotheranostic Targeting Cancer Stem Cells in Human Colorectal Cancer Xenografts.
She X; Qin S; Jing B; Jin X; Sun X; Lan X; An R
Mol Imaging Biol; 2020 Aug; 22(4):1043-1053. PubMed ID: 32125599
[TBL] [Abstract][Full Text] [Related]
14. The hyaluronan receptors CD44 and Rhamm (CD168) form complexes with ERK1,2 that sustain high basal motility in breast cancer cells.
Hamilton SR; Fard SF; Paiwand FF; Tolg C; Veiseh M; Wang C; McCarthy JB; Bissell MJ; Koropatnick J; Turley EA
J Biol Chem; 2007 Jun; 282(22):16667-80. PubMed ID: 17392272
[TBL] [Abstract][Full Text] [Related]
15. Characterization of CD44-positive Cancer Stem-like Cells in COLO 201 Cells.
Okuyama H; Nogami W; Sato Y; Yoshida H; Tona Y; Tanaka Y
Anticancer Res; 2020 Jan; 40(1):169-176. PubMed ID: 31892565
[TBL] [Abstract][Full Text] [Related]
16. Cancer stem cell-related gene expression as a potential biomarker of response for first-in-class imipridone ONC201 in solid tumors.
Prabhu VV; Lulla AR; Madhukar NS; Ralff MD; Zhao D; Kline CLB; Van den Heuvel APJ; Lev A; Garnett MJ; McDermott U; Benes CH; Batchelor TT; Chi AS; Elemento O; Allen JE; El-Deiry WS
PLoS One; 2017; 12(8):e0180541. PubMed ID: 28767654
[TBL] [Abstract][Full Text] [Related]
17. Activation of Matrix Hyaluronan-Mediated CD44 Signaling, Epigenetic Regulation and Chemoresistance in Head and Neck Cancer Stem Cells.
Bourguignon LYW; Earle C; Shiina M
Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28837080
[TBL] [Abstract][Full Text] [Related]
18. Hyaluronic acid hydrogels with defined crosslink density for the efficient enrichment of breast cancer stem cells.
Tan S; Yamashita A; Gao SJ; Kurisawa M
Acta Biomater; 2019 Aug; 94():320-329. PubMed ID: 31125725
[TBL] [Abstract][Full Text] [Related]
19. LGR4 cooperates with PrPc to endow the stemness of colorectal cancer stem cells contributing to tumorigenesis and liver metastasis.
Cheng Q; Zheng H; Li M; Wang H; Guo X; Zheng Z; Chen C; Liu J; Zhan T; Li Z; Wu H; Han J; Liu L; Tang T; Chen Q; Du L
Cancer Lett; 2022 Aug; 540():215725. PubMed ID: 35561877
[TBL] [Abstract][Full Text] [Related]
20. Assessing stemness and proliferation properties of the newly established colon cancer 'stem' cell line, CSC480 and novel approaches to identify dormant cancer cells.
Alowaidi F; Hashimi SM; Alqurashi N; Alhulais R; Ivanovski S; Bellette B; Meedenyia A; Lam A; Wood S
Oncol Rep; 2018 Jun; 39(6):2881-2891. PubMed ID: 29693155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
